SYNH's logo.
Ticker Symbol: SYNH

Syneos Health Inc - Class A

$100.93 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001610950

Company Profile

Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life® visit syneoshealth.com.

Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 8731
Address: 1030 Sync Street
CEO: Alistair Macdonald
Tags:
  • Health Services
  • Services to the Health Industry

Pricing

Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change: $0.01 ( 0.02%)
Days Range: $42.97 - $42.99
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change 0.02%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 103719179

Valuation

Market Cap: 445.8B
PE Ratio: 62.47
EPS (TTM): 0.688

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A